Hyundai Bioland Q1 2026: Revenue +13.5% YoY, Return to Profit, Dividend Maintained
-
Revenue ₩38.2bn (+13.5% YoY), operating profit ₩5.2bn (+4.4% YoY), net profit ₩5.2bn (turnaround from -₩7.0bn)
-
EPS ₩174 (vs -₩234)
-
Debt ratio 15.6%, net cash ₩1.79bn (cash ₩8.27bn - total borrowings ₩6.47bn)
-
FY2025 dividend ₩70/share (total ₩2.1bn) paid in April 2026, policy maintained (target ≥10% of separate operating profit)
-
No share buyback/sale plan
-
KCGS ESG integrated A+ rating (only KOSDAQ company)
-
R&D expense ₩1.61bn (4.2% of sales)
KOSDAQ Filing Information
-
Filing: Quarterly Report (2026.03)
-
Company: HYUNDAI BIOLAND (052260)
-
Submission: HYUNDAI BIOLAND Co.,Ltd.
-
Receipt: 05-15-2026